A Cross-Sectional Study of the Prevalence of Cardiac Valvular Abnormalities in Hyperprolactinemic Patients Treated With Ergot-Derived Dopamine Agonists
dc.contributor.author | Drake, WM | en_US |
dc.contributor.author | Stiles, CE | en_US |
dc.contributor.author | Howlett, TA | en_US |
dc.contributor.author | Toogood, AA | en_US |
dc.contributor.author | Bevan, JS | en_US |
dc.contributor.author | Steeds, RP | en_US |
dc.contributor.author | Valvulopathy, UKDA | en_US |
dc.date.accessioned | 2015-02-25T15:36:52Z | |
dc.date.issued | 2014-01 | en_US |
dc.identifier.issn | 0021-972X | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/6756 | |
dc.format.extent | 90 - 96 | en_US |
dc.relation.ispartof | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | en_US |
dc.title | A Cross-Sectional Study of the Prevalence of Cardiac Valvular Abnormalities in Hyperprolactinemic Patients Treated With Ergot-Derived Dopamine Agonists | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1210/jc.2013-2254 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333402200042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 1 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 99 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Endocrinology [560]